HOUSE

Attorneys at mctlaw File a Second Kratom-Related Wrongful Death Lawsuit in Same WA County as a Recent Multi-Million Dollar Kratom Verdict

Retrieved on: 
Thursday, December 14, 2023
Hush, Cloud, Research, Personal, Clouds House, MIT, Back pain, CLOUD, JANE, Complaint, Cooking, CAG, JOHN, Gardening, Death, DRIP, Health, Hand, Lawyer, LP, Family, HOUSE, Estate, RMH, Superior court, Tobacco

COWLITZ COUNTY, Wash., Dec. 14, 2023 /PRNewswire-PRWeb/ -- A second kratom wrongful death lawsuit has been filed in Cowlitz County, WA following the tragic death of 37-year-old Jordan McKibban. The lawsuit involves multiple defendants, including manufacturers and sellers of kratom brands such as Whole Herbs kratom capsules and Hush Kratom liquid shots, as well as a bulk kratom powder sold by Cloud House Vaporz, for their role in McKibban's kratom induced death. (Case No. 23-2-01183-08 in the Superior Court of the State of Washington in Cowlitz County).

Key Points: 
  • The lawyers at mctlaw file a second kratom wrongful death lawsuit in Cowlitz County, WA following the tragic death of 37-year-old Jordan McKibban.
  • The lawsuit involves multiple defendants, including manufacturers and sellers of kratom brands such as Whole Herbs kratom capsules and Hush Kratom liquid shots, as well as a bulk kratom powder sold by Cloud House Vaporz, for their role in McKibban's kratom induced death.
  • COWLITZ COUNTY, Wash., Dec. 14, 2023 /PRNewswire-PRWeb/ -- A second kratom wrongful death lawsuit has been filed in Cowlitz County, WA following the tragic death of 37-year-old Jordan McKibban.
  • The lawsuit involves multiple defendants, including manufacturers and sellers of kratom brands such as Whole Herbs kratom capsules and Hush Kratom liquid shots, as well as a bulk kratom powder sold by Cloud House Vaporz, for their role in McKibban's kratom induced death.

The Harvard Medical School Master of Science in Media, Medicine, and Health program presents Portraying HIV & AIDS in the Media: How Far Have We Come?

Retrieved on: 
Tuesday, November 28, 2023
PITCH, Yale University, Television, Global health, Master of Science, Epidemiology, Social medicine, HIV/AIDS, Organization, NYPD, CSI, Hospital, Treatment Action Group, LOST, Division, GOOD, EMPIRE, GLEE, Partner, Photography, Human, Right Alliance (Belarus), HIV, MPH, Harvard Medical School, Curriculum, SCANDAL, ANARCHY, AIDS, International Emmy Awards, Doctor of Philosophy, HOUSE, Up, Up and Away, GMHC, Cone Health Women's Hospital, Management, Pharmaceutical industry, Science, Medicine, MD, Health, Brigham

This event is sponsored by the Harvard Medical School Master of Science in Media, Medicine, and Health program in the Harvard Medical School Department of Global Health and Social Medicine.

Key Points: 
  • This event is sponsored by the Harvard Medical School Master of Science in Media, Medicine, and Health program in the Harvard Medical School Department of Global Health and Social Medicine.
  • The Master of Science in Media, Medicine, and Health is the only master's degree program in the United States to offer evidence-based, multidisciplinary storytelling and an arts-driven curriculum focusing on health interventions.
  • In the Department of Global Health and Social Medicine, she directs the Master of Medical Sciences in Global Health Delivery program.
  • We invite you to learn more about these programs in the Harvard Medical School Department of Global Health and Social Medicine.

Leading Smart Kitchen Brand Thermomix Launches First-Ever U.S. Retail Space in Miami

Retrieved on: 
Thursday, November 9, 2023
Mobile, Wireless, Technology, Home Goods, Restaurant, Bar, Food, Beverage, Internet, Hardware, IOT (Internet of Things), Retail, Consumer Electronics, Cream, Taste, Suite, Ice cream, Meal, Relaxation, System, Cooking, History, Family, Consultant, Nintendo Wi-Fi Connection, News, AIA, City, Eventbrite, Thermomix, HOUSE, Love, Smell, Tantalus, MIAMI, Municipal council, Tourism, Nightclub, Video game

Thermomix the leading all-in-one Wi-Fi-connected cooking appliance brand, announced today the opening of the brand’s first-ever retail space in the United States: Thermomix Miami, located at 3450 NW 83rd Avenue, Suite 123, Doral, FL, 33122.

Key Points: 
  • Thermomix the leading all-in-one Wi-Fi-connected cooking appliance brand, announced today the opening of the brand’s first-ever retail space in the United States: Thermomix Miami, located at 3450 NW 83rd Avenue, Suite 123, Doral, FL, 33122.
  • Thermomix is all about celebrating and discovering the love for food – something Miami residents already know and appreciate.
  • ET | “THIRSTY THURSDAY” Q&A LIVESTREAM - As part of opening-day activities, Thermomix will host a “Thirsty Thursday: Live from Thermomix Miami” episode of their popular weekly livestream series.
  • ET | “TIPS & TRICKS” LIVE FROM MIAMI - Thermomix weekly “Tips & Tricks” series will be broadcast live from the new retail space.

New Real-World Data Show TREMFYA® (guselkumab) Was Associated With Clinically Meaningful Improvements in Patient-Reported Outcomes for Adults Living With Active Psoriatic Arthritis

Retrieved on: 
Wednesday, November 8, 2023
St. Joseph's Health Centre, COSMOS, American College, Swedish Health Services, Psoriatic arthritis, University of Washington, Participation, SPRING, Disease, Visual analogue scale, HOUSE, Janssen Pharmaceuticals, University, American College of Rheumatology, Pain, Johnson & Johnson, Patient, ACR, Arthritis, Fatigue, Nursing, Pharmaceutical industry, Birth control

SPRING HOUSE, Pa., Nov. 8, 2023 /PRNewswire/ -- Janssen Pharmaceuticals, Inc., a Johnson & Johnson company, today announced new data from the CorEvitas Psoriatic Arthritis (PsA) and Spondyloarthritis Registry that showed a substantial proportion of people living with treatment-resistant active PsA and using TREMFYA® (guselkumab) in real-world settings reported meaningful improvements in pain, physical function and fatigue through six months.1 Additionally, across the DISCOVER-1, DISCOVER-2 and COSMOS clinical trials, treatment with TREMFYA was associated with higher rates of clinically meaningful improvements in a composite assessment of patient-reported pain, fatigue, physical function, skin problems and PsA-related depression than placebo in the first assessment of the PsA 5-Thermometer Scale Domains (PsA-5T-Ds).2

Key Points: 
  • "People living with active psoriatic arthritis who are treatment-resistant need options that improve debilitating symptoms of their disease, like pain, physical function and fatigue," said Philip Mease, M.D., Swedish Medical Center/Providence St. Joseph Health and University of Washington in Seattle, Washington.a "It is important that we assess patient-reported outcomes in a real-world setting, ensuring that we address unmet needs for people living with this challenging disease."
  • "It is critical that we evaluate patient-reported outcomes to truly understand the lived experiences of patients and better develop and provide treatments in psoriatic disease."
  • Dr. Philip Mease is a paid consultant for Janssen.
  • He has not been compensated for any media work.

The Estée Lauder Companies and NYKAA Announce Winners of the Second Edition of BEAUTY&YOU India

Retrieved on: 
Monday, November 6, 2023
Biotechnology, Cosmetics, Retail, Health, Entertainment, Vitamins, Supplements, Online Retail, Luxury, Film & Motion Pictures, Other Science, Research, Specialty, Science, Fashion, Rhea, Palm oil, Perfume, ESG, Skin care, Breakthrough, Skin, Entrepreneurship, Anaita Shroff Adajania, Multimedia, Senior, Sohrai, City, About You Awards, Biology, Marketing, Partnership, HOUSE, Hariprasad Chaurasia, Food security, ELC, Community, Creative, Safety, Biorefinery, NIV, Philosophy, Memory, Climate change, Management, Film industry, Beauty, Interco, DECIEM

The Estée Lauder Companies (ELC) and NYKAA, one of India’s leading omnichannel beauty and lifestyle retailers, announce the winners of the 2023 BEAUTY&YOU Awards in India.

Key Points: 
  • The Estée Lauder Companies (ELC) and NYKAA, one of India’s leading omnichannel beauty and lifestyle retailers, announce the winners of the 2023 BEAUTY&YOU Awards in India.
  • The winners, listed below, were announced at an awards evening at Snowball Studios, Mumbai, on November 2, 2023.
  • Winners for the Community category were determined via an independent voting process on www.beautyandyouawards.com and an analysis of social engagement.
  • Among other resources, BEAUTY&YOU India will provide winners with financial support, continued mentorship, increased awareness, and distribution support.

Host A Bigger Bolder Tailgate with LITEHOUSE IN THE HOUSE

Retrieved on: 
Thursday, November 2, 2023
Season, Social media, Fructose, Communication, Capital Connection (TV programme), Interest, Marketing communications, HOUSE, House, Marketing, Livestock, Tailgate

SANDPOINT, Idaho, Nov. 2, 2023 /PRNewswire/ -- As the football season excitement continues to build, Litehouse® is taking the tailgating experience to new heights with its "LITEHOUSE IN THE HOUSE" campaign featuring America's No. 1 Ranch Fan.   

Key Points: 
  • The "LITEHOUSE IN THE HOUSE" campaign has yielded exceptional results to-date, including record sales market share this year.
  • One first-prize winner will receive a year's worth of Litehouse ranch dressing and fifty second-prize winners will receive Litehouse Ranch-shaped pillows, the perfect addition to any tailgate hang.
  • "Take it to the House" Instant Wins: Every Sunday, Litehouse will celebrate the first time a player takes it to the house.
  • To learn more about the "LITEHOUSE IN THE HOUSE" Tailgate campaign and for more details for the Ranch Cave Sweepstakes and instant win promotions, follow Litehouse on Instagram or visit www.LitehouseInTheHouse.com .

COVENANT HOUSE TO HOST THOUSANDS FOR ANNUAL GLOBAL SLEEP OUT IN A CALL TO END YOUTH HOMELESSNESS

Retrieved on: 
Wednesday, November 1, 2023
Tao, Kia, Meal, Homelessness, Education, Morgan Stanley, NBA, IKEA, BlackRock, Edrington, Times Square, Take-Two Interactive, Covenant House, Delta Air Lines, NBPA, Sleep, Tri-state, City, Dream, MetLife Stadium, Sleepout, Covenant House Toronto, HOUSE, Cisco, Health, Cisco Network Registrar, Youth activism, AND, Covenant, Bed, Accenture, Cape May Court House, New Jersey, Shutterfly, Government House (New York City), Nightclub, Toy, New York Giants, American Eagle

NEW YORK, Nov. 1, 2023 /PRNewswire/ -- Covenant House, the largest, primarily privately funded charity in the Americas helping homeless and trafficked youth, is galvanizing business leaders, celebrities, individuals, and families from all walks of life this November for Youth Homelessness Awareness Month to put an end to youth homelessness.

Key Points: 
  • On November 16, the organization will host their annual Sleep Out to End Youth Homelessness presented by Cisco at 16 locations around the world.
  • Thousands of participants will give up their beds for one night to raise funds and ensure that young people facing homelessness can sleep safely at Covenant House.
  • "There are 4.2 million youth experiencing homelessness each year in the U.S. alone," said Covenant House President & CEO Bill Bedrossian.
  • For every blanket given to a Sleep Out participant, Chick-fil-A Tri-State will be donating a special gift to every resident at Covenant House New York and Covenant House New Jersey.

New Phase 3 TREMFYA® (guselkumab) Results in Ulcerative Colitis Show a 77 Percent Overall Clinical Response Rate and Early Symptom Improvement

Retrieved on: 
Monday, October 23, 2023
Week, DSM-IV codes, American College, Janssen, Crohn's disease, UC, ACG, American College of Gastroenterology, Ulcerative colitis, HOUSE, Janssen Pharmaceuticals, Cone Health Women's Hospital, Patient, Hospital, Pharmaceutical industry, Birth control

SPRING HOUSE, Pa., Oct. 23, 2023 /PRNewswire/ -- Janssen Pharmaceuticals, Inc., a Johnson & Johnson Company, today announced new data from the QUASAR Phase 3 Induction Study demonstrating the efficacy and safety profile of TREMFYA® (guselkumab), a selective IL-23 p19 inhibitor, in patients with moderately to severely active ulcerative colitis (UC) through 24 weeks.1 High rates of clinical responsea were observed at Weeks 12 or 24, with no new safety signals observed compared to the safety profile of TREMFYA in its approved indications.1 Symptomatic responseb and improvements in patient-reported outcomes of rectal bleeding and absolute stool number were observed as early as one week after a single intravenous (IV) induction dose, with symptomatic response evident in more than two-thirds of patients at Week 12.2 These data are among Janssen's 20 oral and poster presentations at the American College of Gastroenterology (ACG) Annual Scientific Meeting, taking place in Vancouver, Canada, October 20-25, 2023.

Key Points: 
  • Additional data show symptomatic response as early as one week after the first induction dose, with symptomatic improvements increasing through Week 12
    SPRING HOUSE, Pa., Oct. 23, 2023 /PRNewswire/ -- Janssen Pharmaceuticals, Inc., a Johnson & Johnson Company, today announced new data from the QUASAR Phase 3 Induction Study demonstrating the efficacy and safety profile of TREMFYA® (guselkumab), a selective IL-23 p19 inhibitor, in patients with moderately to severely active ulcerative colitis (UC) through 24 weeks.1 High rates of clinical responsea were observed at Weeks 12 or 24, with no new safety signals observed compared to the safety profile of TREMFYA in its approved indications.1 Symptomatic responseb and improvements in patient-reported outcomes of rectal bleeding and absolute stool number were observed as early as one week after a single intravenous (IV) induction dose, with symptomatic response evident in more than two-thirds of patients at Week 12.2 These data are among Janssen's 20 oral and poster presentations at the American College of Gastroenterology (ACG) Annual Scientific Meeting, taking place in Vancouver, Canada, October 20-25, 2023.
  • "Ulcerative colitis is a complex immune-mediated disease that can cause a wide range of often-debilitating symptoms," said study author Jessica R. Allegretti, M.D., Medical Director, Crohn's and Colitis Center at the Brigham and Women's Hospital, Boston, MA, USA.c "Results from the QUASAR studies support the potential of TREMFYA as a durable and fast-acting treatment option."
  • QUASAR Cumulative Clinical Response Results Through Week 24:
    Among TREMFYA-treated patients who were not in clinical response to IV induction therapy at Week 12 and who then received subcutaneous treatment for an additional 12 weeks, 55 percent (66/120) achieved clinical response at Week 24.1
    QUASAR Cumulative Safety Results Through Week 24:
    Safety findings through the final safety visit were consistent with Week 12 results; no new safety signals were identified.1
    QUASAR Early Symptomatic Response Data: Week 1 Through Week 12:
    As early as Week 1 and increasing through Week 12, greater symptomatic improvements were seen in patients treated with TREMFYA compared with placebo with treatment differences for TREMFYA versus placebo evident across outcomes.2

Fix Price Group PLC: Fix Price Board of Directors convenes EGMs on re-domiciliation

Retrieved on: 
Tuesday, October 17, 2023
E-GMS, Moscow Exchange, London Stock Exchange, Republic, HOUSE, Astana International Financial Centre, LSE, Memorandum, Nursultan Nazarbayev International Airport, London, MOEX, Security (finance)

9 October 2023, Limassol, Cyprus – Fix Price Group PLC (LSE and MOEX: FIXP, “Fix Price”, the “Company” or the “Group”), one of the leading variety value retailers globally and the largest in Russia, announces the decision of the Board of Directors to convene two Extraordinary General Meetings of Shareholders (“EGMs”):

Key Points: 
  • 9 October 2023, Limassol, Cyprus – Fix Price Group PLC (LSE and MOEX: FIXP, “Fix Price”, the “Company” or the “Group”), one of the leading variety value retailers globally and the largest in Russia, announces the decision of the Board of Directors to convene two Extraordinary General Meetings of Shareholders (“EGMs”):
    1.
  • As a result of the proposed re-domiciliation, the Company will be struck off the Cyprus Registrar’s register.
  • The Board of Directors has decided to convene the EGMs at 155 Arch.
  • All materials for the EGMs are available on the Company’s website at: https://ir.fix-price.com/investors/general_meetings_of_shareholders/ .

Fix Price Group PLC: Notice of Extraodinary General Meeting of Shareholders - amendment of the memorandum and articles of association

Retrieved on: 
Tuesday, October 17, 2023
Health, Interest, Arch, Republic, Safety, EST, HOUSE, Form, Shareholder, Person, Appendix, Exercise, Regulation, Euroclear, Security (finance), Dam, Proxy, CREST, Meeting

All holders (the “Shareholders”) of shares in the Company (the “Shares”) have the right to attend, speak and vote at the Meeting.

Key Points: 
  • All holders (the “Shareholders”) of shares in the Company (the “Shares”) have the right to attend, speak and vote at the Meeting.
  • Registered Shareholders holding shares in certificated form should complete the form of proxy provided with the Notice of Meeting (the “Form of Proxy”).
  • The Form of Proxy must be deposited in hard copy form by courier or by hand at the Company’s registered office at Arch.
  • The Form of Proxy must be signed and dated by the Shareholder or his/her attorney duly authorised in writing.